# P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

> **NCT02242760** · PHASE2 · COMPLETED · sponsor: **Novan, Inc.** · enrollment: 213 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** SB204 2%
- **DRUG:** SB204 4%
- **DRUG:** Vehicle Gel

## Key facts

- **NCT ID:** NCT02242760
- **Lead sponsor:** Novan, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-06
- **Final completion:** 2015-08
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2023-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242760, "P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02242760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*